Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of LEVOCEE vs Cravit 750 mg in Healthy Thai Volunteers
TCTR20230701005Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levofloxacin (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
levofloxacin
Beyond the preview
Go deeper on TCTR20230701005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230701005.